Publikationsserver
Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential
Mitochondrial dysfunction is strongly implicated in the etiology of idiopathic and genetic Parkinson’s disease (PD). However, strategies aimed at ameliorating mitochondrial dysfunction, including antioxidants, antidiabetic drugs, and iron chelators, have failed in disease-modification clinical tri...
Gespeichert in:
| Autoren: | , , , |
|---|---|
| 格式: | Artikel |
| 語言: | 英语 |
| 出版: |
Philipps-Universität Marburg
2024
|
| 主題: | |
| 在線閱讀: | PDF-Volltext |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
| 總結: | Mitochondrial dysfunction is strongly implicated in the etiology of idiopathic and genetic Parkinson’s disease (PD).
However, strategies aimed at ameliorating mitochondrial dysfunction, including antioxidants, antidiabetic drugs,
and iron chelators, have failed in disease-modification clinical trials. In this review, we summarize the cellular determinants
of mitochondrial dysfunction, including impairment of electron transport chain complex 1, increased oxidative
stress, disturbed mitochondrial quality control mechanisms, and cellular bioenergetic deficiency. In addition,
we outline mitochondrial pathways to neurodegeneration in the current context of PD pathogenesis, and review
past and current treatment strategies in an attempt to better understand why translational efforts thus far have been
unsuccessful. |
|---|---|
| Item Description: | Gefördert durch den Open-Access-Publikationsfonds der UB Marburg. |
| DOI: | 10.1186/s13024-023-00676-7 |